Please login to the form below

Not currently logged in
Email:
Password:

Free cancer drugs for Thailand if changes made

According to local media reports, the Thai health minister has said that Swiss pharmaceutical company Novartis may provide the country with free cancer medicine, if the current drive for generic versions of patented drugs is halted.

According to local media reports, the Thai health minister has said that Swiss pharmaceutical company Novartis may provide the country with free cancer medicine, if the current drive for generic versions of patented drugs is halted.

Thailand is currently embroiled in an battle with global pharmaceutical companies over compulsory licences, which temporarily suspend patent protection.

The government has already issued compulsory licences to obtain generic versions of a heart drug and two HIV medicines.

In September 2007, the government announced it would also seek generic versions of four cancer drugs.

During talks with Novartis, health minister Mongkol Na Songkhla said the company had offered to provide its oncology product Gleevec/ Glivec (imatinib) for free, if Thailand halted its drive to expand its generic drug programme.

If a deal was reached, the government could provide unlimited amounts of the drug through its universal health care scheme, concluded Songkhla.

Per month, Imatinib currently costs up to THB 100,000 (USD 2,950).

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics